New HPV vaccine trial tests fewer shots for teens
NCT ID NCT06632912
Summary
This study is testing a new HPV vaccine to see if a simpler 2-dose schedule for younger girls (9-14 years) works as well as the standard 3-dose schedule for older teens and young women (9-35 years). It will enroll 1,800 female participants to compare the strength and durability of the immune response produced by the different schedules. The main goal is to ensure the vaccine effectively protects against the HPV virus strains that can cause cervical cancer and other diseases.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HPV (HUMAN PAPILLOMAVIRUS)-ASSOCIATED CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Daiyue District Center for Disease Control and Prevention
Tai’an, Shandong, China
-
Liaocheng Center for Disease Control and Prevention
Liaocheng, Shandong, China
-
Shanxian Center for Disease Control and Prevention
Heze, Shandong, China
Conditions
Explore the condition pages connected to this study.